XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 154 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $78,260,105 | +9.1% | 2,032,730 | +1.4% | 0.09% | +3.3% |
| Q1 2023 | $71,733,790 | +85729.6% | 2,004,297 | -5.4% | 0.09% | -25.6% |
| Q4 2022 | $83,577 | -99.9% | 2,119,619 | -7.3% | 0.12% | -1.6% |
| Q3 2022 | $82,574,000 | +49.2% | 2,287,365 | +25.7% | 0.12% | +59.7% |
| Q2 2022 | $55,348,000 | +36.6% | 1,819,476 | +37.3% | 0.08% | +67.4% |
| Q1 2022 | $40,515,000 | – | 1,325,326 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |